StockViz
RANKINGS
bioMérieux S.A.
Paris Stock Exchange:BIM.PA
Sector
Location
Market Cap
USD 16.52 B
Share Price
USD 140.07
Avg Daily Volume
126,647
Change (1 day)
0.12%
Change (1 year)
38.42%
Change (YTD)
30.69%
bioMérieux S.A. Income Statement 2014 - 2024
This table shows the Income Statement for bioMérieux S.A. going from 2014 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
Thermo Fisher Scientific Inc.
USD 429.33
TMO
+1.57
0.37%
Boston Scientific Corporation
USD 104.32
BSX
+0.69
0.67%
Siemens Healthineers AG
USD 55.00
SHL.DE
-0.17
-0.31%
Becton, Dickinson and Company
USD 176.16
BDX
-1.11
-0.63%
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Agilent Technologies, Inc.
USD 121.38
A
+0.72
0.60%
Natera, Inc.
USD 161.76
NTRA
+0.19
0.12%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Baxter International Inc.
USD 31.01
BAX
-0.12
-0.39%
Revvity, Inc.
USD 101.31
RVTY
+0.41
0.41%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.46
603392.SS
-0.14
-1.57%
Qiagen N.V.
USD 48.34
QGEN
-0.30
-0.62%
Exact Sciences Corporation
USD 53.36
EXAS
-0.50
-0.93%
Globus Medical, Inc.
USD 59.17
GMED
-1.40
-2.31%
ConvaTec Group Plc
USD 3.60
CTEC.L
-0.02
-0.56%
Bio-Rad Laboratories, Inc.
USD 251.56
BIO
+0.91
0.36%
Bruker Corporation
USD 42.45
BRKR
-0.01
-0.02%
Hangzhou Tigermed Consulting Co., Ltd.
USD 5.08
3347.HK
+0.00
0.09%